UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 640

Sortiert nach

Risk of development of diabetes mellitus after diagnosis of gestational diabetes

Canadian Medical Association journal, 2008-07, Vol.179 (3), p.229

2008

Volltextzugriff (PDF)

Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials

Diabetes, obesity & metabolism, 2013-02, Vol.15 (2), p.175-184

2013

Volltextzugriff (PDF)

Short-term intensified insulin treatment in type 2 diabetes: long-term effects on β-cell function

Diabetes, obesity & metabolism, 2012-10, Vol.14 (s3), p.161-166

2012

Volltextzugriff (PDF)

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

Diabetologia, 2009, Vol.52 (1), p.17-30

2009

Volltextzugriff (PDF)

Fetal sex and maternal risk of pre‐eclampsia/eclampsia: a systematic review and meta‐analysis

BJOG : an international journal of obstetrics and gynaecology, 2017-03, Vol.124 (4), p.553-560

2017

Volltextzugriff (PDF)

A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)

Diabetes, obesity & metabolism, 2014-07, Vol.16 (7), p.636-644

2014

Volltextzugriff (PDF)

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

Diabetes, obesity & metabolism, 2009-02, Vol.11 (2), p.157-166

2009

Volltextzugriff (PDF)

Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme

Diabetes, obesity & metabolism, 2012-01, Vol.14 (1), p.77-82

2012

Volltextzugriff (PDF)

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy : A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

Diabetologia, 2006-08, Vol.49 (8), p.1711-1721

2006

Volltextzugriff (PDF)

Alternative routes of insulin delivery

Diabetic medicine, 2003-11, Vol.20 (11), p.886-898

2003

Volltextzugriff (PDF)

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial

Diabetic medicine, 2013-11, Vol.30 (11), p.1298-1304

2013

Volltextzugriff (PDF)

A meta-analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia

Diabetic medicine, 2016-04, Vol.33 (4), p.478-487

2016

Volltextzugriff (PDF)

Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study

Diabetes, obesity & metabolism, 2010-09, Vol.12 (9), p.780-789

2010

Volltextzugriff (PDF)

Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme

Diabetes, obesity & metabolism, 2013-01, Vol.15 (1), p.42-54

2013

Volltextzugriff (PDF)

Effect of short-term intensive insulin therapy on the incretin response in early type 2 diabetes

Diabetes & metabolism, 2019-04, Vol.45 (2), p.197-200

2019

Volltextzugriff (PDF)

Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: Update regarding the thiazolidinediones

Diabetologia, 2008-01, Vol.51 (1), p.8-11

2008

Volltextzugriff (PDF)

Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia

Diabetologia, 2010-02, Vol.53 (2), p.268-276

2010

Volltextzugriff (PDF)

Clinical predictors and time course of the improvement in β-cell function with short-term intensive insulin therapy in patients with Type 2 diabetes

Diabetic medicine, 2015-05, Vol.32 (5), p.645-652

2015

Volltextzugriff (PDF)

Glycaemic efficacy of canagliflozin is largely independent of baseline β-cell function or insulin sensitivity

Diabetic medicine, 2016-12, Vol.33 (12), p.1744-1747

2016

Volltextzugriff (PDF)

Glycaemic efficacy of canagliflozin is largely independent of baseline [beta]-cell function or insulin sensitivity

Diabetic medicine, 2016-12, Vol.33 (12), p.1744

2016

Volltextzugriff (PDF)

Response to the Letter by Kalra S. et al

The journal of clinical endocrinology and metabolism, 2015-11, Vol.100 (11), p.L118-L118

2015

Volltextzugriff (PDF)

Adiponectin and beta cell dysfunction in gestational diabetes : pathophysiological implications

Diabetologia, 2005-05, Vol.48 (5), p.993-1001

2005

Volltextzugriff (PDF)

Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes risk

Diabetes, obesity & metabolism, 2012-09, Vol.14 (9), p.821-825

2012

Volltextzugriff (PDF)

Effects of Insulin in Relatives of Patients with Type 1 Diabetes Mellitus

The New England journal of medicine, 2002-05, Vol.346 (22), p.1685-1691

2002

Volltextzugriff (PDF)

Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies

Diabetes care, 2000-07, Vol.23 (7), p.962-968

2000

Volltextzugriff (PDF)

1 – 25 von 640

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(586)
Mit Volltextzugriff
(529)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(386)
Science & Technology
(381)
Life Sciences & Biomedicine
(370)
Male
(265)
Female
(262)
Endocrinology & Metabolism
(207)
Adult
(200)
Biological And Medical Sciences
(174)
Middle Aged
(168)
Diabetes
(163)
Medical Sciences
(161)
Endocrinopathies
(101)
Risk Factors
(99)
Endocrine Pancreas. Apud Cells
(92)
Diabetes. Impaired Glucose Tolerance
(91)
Blood Glucose - Metabolism
(81)
Adolescent
(77)
Aged
(77)
Insulin
(71)
Hypoglycemic Agents - Therapeutic Use
(63)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Risk of development of diabetes mellitus after diagnosis of gestational diabetes

Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials

Short-term intensified insulin treatment in type 2 diabetes: long-term effects on β-cell function

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

Fetal sex and maternal risk of pre‐eclampsia/eclampsia: a systematic review and meta‐analysis

A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy : A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

Alternative routes of insulin delivery

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial

A meta-analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia

Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study

Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme

Effect of short-term intensive insulin therapy on the incretin response in early type 2 diabetes

Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: Update regarding the thiazolidinediones

Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia

Clinical predictors and time course of the improvement in β-cell function with short-term intensive insulin therapy in patients with Type 2 diabetes

Glycaemic efficacy of canagliflozin is largely independent of baseline β-cell function or insulin sensitivity

Glycaemic efficacy of canagliflozin is largely independent of baseline [beta]-cell function or insulin sensitivity

Response to the Letter by Kalra S. et al

Adiponectin and beta cell dysfunction in gestational diabetes : pathophysiological implications

Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes risk

Effects of Insulin in Relatives of Patients with Type 1 Diabetes Mellitus

Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies

Suchergebnisse filtern